| INTRODUCTION
In the USA, 9.3% of the population has diabetes (Centers for Disease Control and Prevention 2014); globally, 592 million (Guariguata et al., 2014) The prevalence of sleep disturbance is increasing at an alarming rate, particularly in patients with T2DM. It was reported that 39.4% and 55.0% of them have short sleep duration (<6.5 hr per night) (Ohkuma et al., 2014) and poor sleep quality (Luyster & DunbarJacob, 2011) . Evidence indicates that sleep disturbance and glucose regulation form a cycle through multiple pathophysiological pathways (Reutrakul & Van Cauter, 2014) . Sleep disturbance is associated with higher risk of T2DM (Cappuccio, D'Elia, Strazzullo, & Miller, 2010) . However, despite growing concern regarding the effects of sleep disturbance on health, few studies have examined the relationship between sleep disturbance and diabetes-related health outcomes, particularly glycaemic control in people who already have T2DM.
Glycaemic control is the regulation and maintenance of the blood glucose levels within the normal range and is best evaluated by the combination of blood glucose and glycated haemoglobin A1c (HbA1c) (American Diabetes Association 2017). HbA1c is an indicator of the overall glucose level for the past 2-3 months and has been widely used as the "gold standard" for glycaemic control (Lenters-Westra, Schindhelm, Bilo, & Slingerland, 2013) . In people with T2DM, glycaemic control is paramount for maintaining health and reducing the risks of diabetes complications, including retinopathy, neuropathy, and nephropathy (American Diabetes Association 2017).
Glycaemic control may be affected by multiple biological, psychological, and behavioural factors; sleep plays a potential role among these factors. Recently, Lee and colleagues (Lee, Ng, & Chin, 2016) conducted a meta-analysis of 20 studies and examined the impact of sleep duration and sleep quality on glycaemic control in people with T2DM. It was reported that short and long sleep duration, as well as poor sleep quality, was related to an increased HbA1c. The evidence provided by Lee and colleagues is compelling; however, there have been new publications since their review, and independent reviews of similar topics by different teams may be useful in adding to the evidence and expanding the science (Siontis, Hernandez-Boussard, & Ioannidis, 2013) . Therefore, we independently reviewed the evidence from current studies, aiming to expand and strengthen our knowledge in the relationship between sleep disturbance and glycaemic control in people with T2DM.
| Aims
The aim of this integrative review was to explore and synthesise current evidence to determine whether sleep disturbance, defined as poor sleep quality or abnormal sleep duration, is related to glycaemic control in adults with T2DM. The findings will address research and methodological gaps and provide further evidence about the relationship between sleep and diabetes.
| METHODS

| Design
Unlike a meta-analysis, which requires homogeneity in the measurement of the construct of interest and similar conceptual hypothesis addressed in the primary sources (Cooper, 1998) , an integrative review allows for the synthesis of both observational and experimental studies, thereby providing a comprehensive understanding of a topic of interest (Whittemore & Knafl, 2005) . Thus, Whittemore and Knafl's methodology (Whittemore & Knafl, 2005) for integrative review was employed to enhance the validity of this review.
| Inclusion and exclusion criteria
This integrative review included original studies that were conducted in adults with T2DM. The study population was restricted to T2DM adults because physiological, social and behavioural pathways influencing both sleep and glycaemic control are different in adults and children, as well as in type 1 diabetes and T2DM. Based on our definition of sleep disturbance, the variables of interest included sleep quality or duration. Similarly, the other inclusion criteria is that physiological indicator of glycaemic control (e.g., blood glucose or HbA1c) should be available. Additionally, only studies published in English were included. Review papers and abstracts presented at scientific What does this paper contribute to the wider global clinical community?
• Identifies that sleep disturbance, particularly impaired sleep quality, is related to glycaemic control in people with type 2 diabetes.
• Demonstrates the importance of healthy sleep and the need for conducting sleep-related assessment and intervention in people with diabetes.
• Lends evidence to current clinical practice regarding the necessity of incorporating sleep-related self-care into the overall self-care repertoire.
conferences were excluded. Pregnancy-related physiological and psychological changes might confound the relationship between sleep and glycaemic control. Thus, studies conducted in people with gestational diabetes were excluded. Studies focused on sleep architecture, sleep stages, or sleep pattern was excluded. Sleep architecture is the basic structural organisation of normal sleep and can be classified into nonrapid eye movement (NREM) sleep and rapid eye movement (REM) sleep (Colten & Altevogt, 2006 
| Quality appraisal
The Crowe Critical Appraisal Tool (CCAT) (Crowe, 2013) was used to evaluate the quality of each study from eight aspects (e.g., design, sampling, and data collection). It has a global score ranging from 0-40. Higher scores indicate higher quality. No cut-off point of the appraisal score is suggested as an indicator for exclusion (Whittemore & Knafl, 2005) . Thus, all of the eligible papers were included in this review.
| Data abstraction and synthesis
A table matrix was used for efficient and reliable abstraction of pertinent information. Data were abstracted, coded, and tabulated into the matrix. Constant comparison was conducted to identify the relationships between sleep disturbance and glycaemic control. Similar patterns were clustered under the same themes, and discrepancies between studies were compared. A pooled meta-analysis is unlikely to be done due to the heterogeneity of the primary sources (Whittemore & Knafl, 2005) . Thus, the narrative synthesis was conducted to summarise and explain the findings. 
| Study quality
The overall CCAT score ranged from 25-39 (Table 1) , indicating varying levels of study quality. Specifically, the four dissertation work (Giacinto, 2016; Kwan, 2013; Moehling, 2016; Tannas, 2012) Although all eligible studies, regardless of the CCAT score, were included, the scoring provided comprehensive evaluation about the methodological soundness of each one.
| Study characteristics
The articles were published between 2006-2016. As is shown in Table 1 , the studies were conducted in various countries, including the USA, Japan, Italy and the Netherlands. Among the 26 studies, a majority of the studies used a cross-sectional design. A total of 13,757 participants were recruited. Within individual studies, the sample size ranged from 9-4,402. Five studies were nationwide (Cooper et al., 2015; Giacinto, 2016; Knutson, Van Cauter, Zee, Liu, & Lauderdale, 2011; Nefs et al., 2015; Williams, Hu, Patel, & Mantzoros, 2007) , and the remaining recruited participants from clinics or hospitals. Both objective and subjective methods were used to measure sleep disturbance such as actigraphy and Pittsburgh Sleep Quality Index (PSQI). Glycaemic control was primarily measured by HbA1c or blood glucose (Table 1) .
| Participant characteristics
In the studies reporting participant age range, the average age was between 26.3-66.6 years old. Two studies only recruited women (Tannas, 2012; Williams et al., 2007) ; the remaining included both genders. The average diabetes duration ranged from 5.4 years (Jennum et al., 2015) to 18.1 years (Yagi et al., 2011) . The average BMI ranged from 24.7 kg/m 2 (Yagi et al., 2011) to 37.9 kg/m 2 (Knutson et al., 2011) . Overall, glycaemic control across studies, as measured
by HbA1c (7.0%-8.9%), was higher than recommended by the American Diabetes Association (American Diabetes Association 2017), except two studies (6.7% [Jennum et al., 2015] and 6.9% [Keskin et al., 2015] ).
| Relationship between sleep disturbance and glycaemic control
Findings regarding the relationship between sleep disturbance and glycaemic control were inconsistent across studies. Three main patterns were identified and thus were clustered under the following three themes: sleep disturbance unrelated to glycaemic control;
inconclusive relationships between sleep duration and glycaemic control; and sleep quality related to glycaemic control.
| Sleep disturbance unrelated to glycaemic control
Nine studies found no significant associations between sleep disturbance and glycaemic control (Cho, Lee, Ryu, Choi, & Kim, 2014; Cooper et al., 2015; Garfinkel et al., 2011; Jain et al., 2012; Moehling, 2016; Rajendran, Parthsarathy, Tamilselvan, Seshadri, & Shuaib, 2012; Tannas, 2012; Williams et al., 2007; Yagi et al., 2011) . Among the nine studies, seven used a cross-sectional design and the sleep measures included only self-reported sleep duration or sleep quality.
One of the remaining two studies was a randomised controlled trial examining the relationship between glycaemic control and objective sleep, however, the sample included only 36 adults with T2DM and insomnia (Garfinkel et al., 2011) . In the other quasi-experimental study (Tannas, 2012) , Tannas recruited only nine participants and did not include a control group.
| Inconclusive relationships between sleep duration and glycaemic control
Five studies explored the nonlinear (U-shaped) relationship between sleep duration and glycaemic control. Compared with patients who slept 6.5-7.4 hr, patients with shorter or longer sleep duration tended to have higher levels of fasting glucose and HbA1c (p trend value < .01) (Ohkuma et al., 2014) . Cooper and colleagues (Cooper et al., 2015) also reported that the lowest HbA1c level tended to be in those who slept 7-8 hr, although the trend was not significant.
Compared to normal sleep duration (6-9 hr), long sleep duration (over 9 hr) increased the likelihood of having poor glycaemic control (OR = 0.76, p = 0.038) (Giacinto, 2016) . In contrast, the U-shaped relationship between self-reported sleep duration and HbA1c was not found in two studies (Mahmood et al., 2013; Williams et al., 2007) .
In the eight studies that examined the linear relationship between sleep duration and glycaemic control, six did not find a significant association. HbA1c or fasting glucose was not related to sleep duration measured by objective EEG (Yoda et al., 2015) , actigraphy (Knutson et al., 2011; Kwan, 2013; Trento et al., 2008) , or self-reported questionnaire (Cho et al., 2014; Giacinto, 2016 After duplicates removal n = 1281
Title & abstract review n = 1281
Excluded n = 1186
Excluded n = 69 Non-English (7); Gestational diabetes (5) Review (5) • Shorter sleep duration were associated with higher HbA1c (r = À.168, p < .05), but not PSQI score (r = .097, p > .05)
35
Clinic (210) Self-reported: sleep duration;
• Shorter sleep duration was associated with higher HbA1c (b = À.019, p = .008), and sleep duration explained an additional 2.8% of the variance in HbA1c
Medical record: HbA1c
Nefs (2015), the Netherlands Cross-sectional PSQI: sleep quality (poor >5);
• In T2DM, people with poor sleep quality had poor glycaemic control (p = .02)
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Nationwide (361 out of the 628 participants were T2DM) Self-reported: HbA1c (poor >7%)
• Controlling for confounders (age, gender, and complications), HbA1c was not a predictor of poor sleep quality (OR = 1.01, p > .05)
Cooper (2015), UK Cross-sectional Self-reported and movement sensor data: sleep duration;
• Ohkuma (2014), Japan Cross-sectional Self-reported sleep duration (<5.5 hr, 5.5-6.4 hr, 6.5-7.4 hr, 7.5-8.4 hr, >8.5 hr);
• Compared with patients who slept 6.5-7.4 hr, those with shorter (<5.5 hr, 5.5-6.4 hr) or longer (7. | 4059 duration explained additional 2.8% of the variance in HbA1c, after controlling for covariates (Reutrakul et al., 2015) .
| Sleep quality related to glycaemic control
Fourteen of the 22 studies examining the relationship between sleep quality and glycaemic control found a significant association. Sleep quality has been objectively measured by EEG, polysomnography (PSG) or actigraphy. Objective sleep latency (r = À.342 to À.292, p < .05) (Yoda et al., 2015) and sleep efficiency (r = À.29, p = .047) (Trento et al., 2008) was negatively correlated with glycaemic control.
Greater sleep fragmentation was associated with higher fasting glucose (b = .089, p < .05) (Knutson et al., 2011) and HbA1c (r = .31, p = .031) (Trento et al., 2008) . Similarly, sleep quality operationalised as nocturnal awakening was related to hypoglycaemia (Jennum et al., 2015) . Sleep quality was also subjectively measured by self-reported questionnaires such as PSQI, and similar findings have been reported.
Subjective poor sleep quality was correlated with poorer glycaemic control (r = .14-.30, p < .05) (Keskin et al., 2015; Knutson et al., 2006; Kwan, 2013; Mahmood et al., 2013; Tanik et al., 2016; Tsai et al., 2012) , although the relationship became nonsignificant after adjustment for confounders in two studies (Mahmood et al., 2013; Osonoi et al., 2015) . People with poor sleep quality had poor glycaemic control (p < .05) (Lecube et al., 2016; Nefs et al., 2015) . Sleep disturbance also contributed unique variance in HbA1c (b = .043-.27, p < .05) (Czech, Orsillo, Pirraglia, English, & Connell, 2015; Knutson et al., 2006) or posed as a risk factor for poor glycaemic control (OR = 6.94, p = .050) (Tsai et al., 2012) .
| DISCUSSION
This review addresses the relationship between sleep disturbance and glycaemic control in adults with T2DM and builds on the recent review by Lee and colleagues (Lee et al., 2016) . In this review, we systematically examined 26 studies. We found that sleep quality is related to glycaemic control in people with T2DM. However, evidence supporting a significant relationship between sleep duration and glycaemic control is not strong.
Our finding of the significant relationship between sleep quality and glycaemic control is consistent with current evidence. Lee et al. reported that poor sleep quality was associated with an increased HbA1c (weighted mean difference = 0.35%; 95% CI = 0.12, 0.58) in people with T2DM. A similar pattern was also observed in people with type 1 diabetes; good sleep quality was related to lower HbA1c (mean difference = À0.19%; 95% CI = À0.30, À0.08) (Reutrakul et al., 2016) . The mechanisms underlying the relationship between sleep quality and glycaemic control remain unclear. Reutrakul and
Van Cauter proposed physiological pathways involved in the detrimental effect of sleep disturbance on metabolism. For instance, short sleep duration and poor sleep quality might cause decreased brain glucose utilisation, which leads to hyperglycaemia. An alteration in appetite-regulating hormones, including ghrelin and leptin, caused by sleep disturbance might also play a role (Reutrakul & Van Cauter, 2014) . Additionally, Larcher and colleagues suggest there is a behavioural mechanism linking sleep disturbance and diabetes. Sleep disturbance likely increases calorie intake, decreases energy expenditure, and leads to impaired decision-making (e.g., unhealthy
food choice and sedentary behaviours), which will ultimately increase the risk of T2DM or poor glycaemic control (Larcher, Benhamou, Pepin, & Borel, 2015) .
There is little evidence of a significant association between sleep duration and glycaemic control. Lee and colleagues reported that, compared to normal sleep duration, both short and long sleep duration were related to an increased HbA1c (weighted mean difference 0.23% and 0.13%, respectively); suggesting a U-shaped curve (Lee et al., 2016) . Our findings differed from those of Lee et al., in that there was no strong evidence in support of a relationship between sleep duration and glycaemic control. The inconsistent findings could be explained by lack of standard classifications for short, normal, and long sleep duration between studies. Sleep duration measurement could also explain the inconsistency in findings. In the review by Lee et al., most studies measured sleep duration subjectively, while in our review, we included studies that used both subjective and objective measures of sleep duration.
Variances in the quality of the primary sources included in this review could explain the inconsistent findings regarding the relationship between sleep disturbance and glycaemic control. The studies'
CCAT scores ranged from 25-39, indicating much variability in the quality, particularly the two dimensions included in the CCAT: study design and sampling.
| Study design
Study design elements within CCAT, including the inclusion of confounders and measurement (Crowe, 2013) , may help to explain the inconsistent findings. The choice of confounding variables or lack thereof may underestimate or overestimate the relationship between sleep disturbance and glycaemic control. Patient demographics (e.g., age and gender) and diabetes-related factors (e.g., diabetes duration)
have been related to glycaemic control (de Pablos-Velasco et al., 2014) , and therefore might need to be adjusted. The potential confounding effect of these variables was further demonstrated in a current study where a significant U-shaped relationship between sleep duration and glycaemic control was reported. When age, gender, and diabetes duration were controlled, the relationship was no longer significant (Kim et al., 2013) . Similarly, in our review, the relationship between sleep and glycaemic control lost significance after controlling for confounders in several studies (Mahmood et al., 2013; Nefs et al., 2015; Osonoi et al., 2015) . There is little consensus regarding choice of control variables when examining the relationship between sleep and diabetes. Future research might help to clarify potential diabetes and non-diabetes-related factors that may confound these relationships.
Measures of sleep varied across studies, yet psychometric properties of the instruments were rarely reported. Lack of evidence for validity and reliability could also weaken the reported associations between sleep disturbance and glycaemic control.
Additionally, the discrepancy between subjective and objective measures of sleep disturbance might account for the inconsistency between study findings. When sleep quality was objectively measured (Jennum et al., 2015; Knutson et al., 2011; Trento et al., 2008; Yoda et al., 2015) , poor sleep quality was associated with poor glycaemic control. In contrast, subjectively measured sleep quality was not related to glycaemic control in several studies (Cho et al., 2014; Nefs et al., 2015; Rajendran et al., 2012; Reutrakul et al., 2015; Yagi et al., 2011) . Objective and subjective measures of sleep provide different and unique portrayals of an individual's sleep (Landry, Best, & Liu-Ambrose, 2015) . People might have misperceptions of their sleep time. Thus, their subjective report of nightly sleep does not necessarily align with objective measures, such as PSG (Bathgate, Edinger, Wyatt, & Krystal, 2016) . Significant relationships between glycaemic control and subjectively measured sleep disturbance might be missed if only objective measures are used. However, in the clinical setting, the subjective interpretation of sleep disturbance may affect patients' daily lives. Thus, any conclusion regarding the relationship between sleep disturbance and glycaemic control must account for variations in measures.
Future research using both objective and subjective sleep measures will enable us to compare their respective association with glycaemic control.
| Sampling
Variations in sampling protocols, such as sample size, could also account for the inconsistent findings. Frequently, statistical significance is a result of a large sample size (Ellis, 2009) . In studies that found a significant nonlinear relationship between glycaemic control and sleep duration, the significance could be explained by the large sample sizes; each included over 2,000 participants (Giacinto, 2016; Ohkuma et al., 2014) . Meanwhile, low statistical power, such as inadequate sample size, can undermine the likelihood of detecting the significance (Button et al., 2013) . For instance, in the experimental study that included nine participants (Tannas, 2012) , the study is very likely underpowered, and therefore the significant relationship between sleep disturbance and glycaemic control could have been missed. In view of the studies included in this review, many did not address the adequacy of the sample size. Therefore, interpretation of the findings from each study needs to take into consideration the sample size.
Variability in the inclusion and exclusion criteria across studies, particularly diabetic neuropathy, could explain the inconsistent findings.
Diabetic neuropathy is a progression pattern of sensory loss due to diabetes-related metabolic and neurodegenerative changes. It has been suggested as an independent risk factor for sleep disturbance ( € Ozt€ urk et al., 2015) . In this review, the inclusion of participants with diabetic neuropathy varied. For instance, one study only recruited participants without neuropathy (Trento et al., 2008) . In contrast, the other study only included those with painful neuropathy (Tanik et al., 2016) . This variation did not make a clear and consistent impact on the findings regarding the relationship between sleep disturbance and glycaemic control. However, the effect of sleep disturbance on glycaemic control differed when participants were stratified by the number of complications of diabetes, including painful neuropathy (Knutson et al., 2006) .
This further suggests that variations in the inclusion of people with diabetic complications need to be accounted for when examining the relationship between sleep disturbance and glycaemic control.
| Limitations
In this integrative review, we systematically reviewed current evidence regarding the relationship between sleep disturbance and glycaemic control in adults with T2DM. Using a narrative synthesis, we added new evidence to our current understanding of the relationship between sleep and diabetes and shed more light on an important health issue that is mostly under-researched. Nevertheless, this review has several limitations. Although we conducted an exhaustive search, the gray literature was not fully captured, as non-English papers and unpublished reports were not included. All eligible studies were included in the analysis regardless of the quality due to a paucity of existing studies. This was somewhat mitigated by the use of systematic quality appraisal, which informed us of the strength, weakness, and overall quality of each study. This enabled us to weigh and report the strength of evidence. Additionally, the inclusion of all studies regardless of the quality score present us the state of science in this particular research area. Another limitation is the lack of standardisation of sleep disturbance measurement. Objective and subjective measures evaluate different aspects of sleep. However, most of the studies used only subjective or objective sleep assessment. In addition, the adequacy of the sample size was not addressed, which might have underestimated or overestimated the relationship. Finally, the causality between sleep disturbance and glycaemic control cannot be determined as most of the study used a cross-sectional design. Reciprocal relationships between sleep disturbance and glycaemic control have been proposed. It is also possible that glycaemic control could affect sleep.
| CONCLUSION
The prevalence of T2DM and sleep disturbance is increasing. The role sleep plays in diabetes development remains to be examined.
This review provided further evidence for the importance of sleep in the diabetes population. Strong evidence supports a significant relationship between sleep quality and glycaemic control. Nevertheless, the relationship between sleep duration and glycaemic control needs to be further investigated. Future research using a more rigorous design would shed more lights on this topic. Specifically, these stud- Thus, the complexity of sleep disturbance needs to be underscored in health care professionals so that they can provide sleep-related education for patients. In clinical practice, nurse practitioners need to pay attention to patients' complaints about their sleep and make referrals if necessary. This review provides further evidence for the incorporation of routine sleep assessment and education, which may help to change current diabetes education guidelines. Good sleep quality can reduce HbA1c by 0.35%, which can be translated to 3% and 5% reduction in death and microvascular complications, respectively (Lee et al., 2016) .
Thus, collaborations among clinicians, nurses, and patients are needed to better manage sleep disturbance.
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